(MENAFN- Investor Brand Network) Lophora , a Danish biotech advancing next-generation psychedelic therapies, announced the first subjects have been dosed in its Phase 1 clinical trial of LPH-5, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback